ANTICOAGULANT SODIUM CITRATE SOL 4% USP DIN 00572357
Status: Cancelled Post Market
Holder: CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
Molecule: SODIUM CITRATE
Health Canada record
| Active ingredient(s) | SODIUM CITRATE 4 % |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS |
| Original market date | 31-Dec-1988 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM CITRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00060313 | ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML | BAXTER CORPORATION | Solution | SODIUM CITRATE 4 G | Marketed |
| 02529637 | ANTICOAGULANT SODIUM CITRATE SOLUTION, USP | FRESENIUS KABI CANADA LTD | Solution | SODIUM CITRATE 4 G | Marketed |
| 02344416 | ANTICOAGULANT SODIUM CITRATE SOLUTION USP | FENWAL INC | Solution | SODIUM CITRATE 4 G | Cancelled Post Market |
| 00376469 | BROMO SELTZER | WARNER-LAMBERT CANADA INC. | Powder | SODIUM CITRATE 3.5 G | Cancelled Post Market |
| 02038234 | LEMON ENO 2650MG/PCK | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | Powder | SODIUM CITRATE 2.65 G | Cancelled Post Market |
| 02063905 | MICROLAX MICRO ENEMA | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Enema; Liquid | SODIUM CITRATE 90 MG; SODIUM LAURYL SULFOACETATE 9 MG; SORBITOL 625 MG | Cancelled Post Market |
| 02004666 | MICROLAX MICRO-ENEMA | KABI PHARMACIA CANADA INC. | Liquid | SODIUM CITRATE 90 G; SODIUM LAURYL SULFOACETATE 9 G; SORBITOL 625 G | Cancelled Post Market |
| 02038226 | ORANGE ENO 2645MG/PCK | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | Powder | SODIUM CITRATE 2.645 G | Cancelled Post Market |
International API supply for SODIUM CITRATE
13 active FDA Drug Master Files.
Request a quote for ANTICOAGULANT SODIUM CITRATE SOL 4% USP